TMO

SEC source: 0001127602-24-007642 · form4.xml · nonDerivative · entry 8

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,485.383

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-24-007642 · form4.xml · derivative · entry 20

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,300

Underlying: Common Stock · 10,000 shares

Expires 2024-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-24-007642 · form4.xml · nonDerivative · entry 7

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,485.383

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $566.36 to $567.24, inclusive.

SEC source: 0001127602-24-007642 · form4.xml · nonDerivative · entry 6

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,070.383

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.29 to $566.28, inclusive.

SEC source: 0001127602-24-007642 · form4.xml · nonDerivative · entry 5

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 131,968.383

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.26 to $565.25, inclusive.

SEC source: 0001127602-24-007642 · form4.xml · nonDerivative · entry 4

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 135,468.383

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $563.22 to $564.19, inclusive.

SEC source: 0001127602-24-007642 · form4.xml · nonDerivative · entry 3

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 137,185.383

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $562.20 to $563.15, inclusive.

SEC source: 0001127602-24-007642 · form4.xml · nonDerivative · entry 2

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,185.383

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $561.18 to $561.85, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13) and (14) to this Form 4.

SEC source: 0001127602-24-007642 · form4.xml · nonDerivative · entry 1

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,485.383

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-24-006820 · form4.xml · nonDerivative · entry 1

Boxer Michael A · CIK 0001726596 · SVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,374.24

F1 · balance_after: Reflects a downward adjustment of 88 shares of a performance-based restricted stock unit award granted on February 23, 2021. On February 23, 2022, the reporting person reported the acquisition of the performance-based restricted stock unit award. One-third of the shares vested on February 23, 2022, one-third of the shares vested on February 23, 2023, and the remaining one-third vested on February 23, 2024, subject to adjustment based on the Company's relative total shareholder return ("TSR") over the measurement period starting on January 1, 2021, through to December 31, 2023. As a result of the Company's relative TSR, the third tranche was adjusted downward by 15%. As such, the reporting person received 88 less shares than the amount initially reported.

SEC source: 0001127602-24-006821 · form4.xml · nonDerivative · entry 1

Britt Lisa P. · CIK 0001676320 · Sr. VP and Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,514.762

F1 · balance_after: Reflects a downward adjustment of 92 shares of a performance-based restricted stock unit award granted on February 23, 2021. On February 23, 2022, the reporting person reported the acquisition of the performance-based restricted stock unit award. One-third of the shares vested on February 23, 2022, one-third of the shares vested on February 23, 2023, and the remaining one-third vested on February 23, 2024, subject to adjustment based on the Company's relative total shareholder return ("TSR") over the measurement period starting on January 1, 2021, through to December 31, 2023. As a result of the Company's relative TSR, the third tranche was adjusted downward by 15%. As such, the reporting person received 92 less shares than the amount initially reported.

SEC source: 0001127602-24-006823 · form4.xml · nonDerivative · entry 1

Holmes Joseph R. · CIK 0001839832 · VP & Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,795.3017

F1 · balance_after: Reflects a downward adjustment of 15 shares of a performance-based restricted stock unit award granted on February 23, 2021. On February 23, 2022, the reporting person reported the acquisition of the performance-based restricted stock unit award. One-third of the shares vested on February 23, 2022, one-third of the shares vested on February 23, 2023, and the remaining one-third vested on February 23, 2024, subject to adjustment based on the Company's relative total shareholder return ("TSR") over the measurement period starting on January 1, 2021, through to December 31, 2023. As a result of the Company's relative TSR, the third tranche was adjusted downward by 15%. As such, the reporting person received 15 less shares than the amount initially reported.

SEC source: 0001127602-24-006826 · form4.xml · nonDerivative · entry 1

Lagarde Michel · CIK 0001518973 · Executive Vice President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,147.063

F1 · balance_after: Reflects a downward adjustment of 304 shares of a performance-based restricted stock unit award granted on February 23, 2021. On February 23, 2022, the reporting person reported the acquisition of the performance-based restricted stock unit award. One-third of the shares vested on February 23, 2022, one-third of the shares vested on February 23, 2023, and the remaining one-third vested on February 23, 2024, subject to adjustment based on the Company's relative total shareholder return ("TSR") over the measurement period starting on January 1, 2021, through to December 31, 2023. As a result of the Company's relative TSR, the third tranche was adjusted downward by 15%. As such, the reporting person received 304 less shares than the amount initially reported.

SEC source: 0001127602-24-006829 · form4.xml · nonDerivative · entry 1

Pettiti Gianluca · CIK 0001844600 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,010.154

F1 · balance_after: Reflects a downward adjustment of 239 shares of a performance-based restricted stock unit award granted on February 23, 2021. On February 23, 2022, the reporting person reported the acquisition of the performance-based restricted stock unit award. One-third of the shares vested on February 23, 2022, one-third of the shares vested on February 23, 2023, and the remaining one-third vested on February 23, 2024, subject to adjustment based on the Company's relative total shareholder return ("TSR") over the measurement period starting on January 1, 2021, through to December 31, 2023. As a result of the Company's relative TSR, the third tranche was adjusted downward by 15%. As such, the reporting person received 239 less shares than the amount initially reported.

SEC source: 0001127602-24-006832 · form4.xml · nonDerivative · entry 1

Williamson Stephen · CIK 0001648929 · Sr. VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,253.346

F1 · balance_after: Reflects a downward adjustment of 245 shares of a performance-based restricted stock unit award granted on February 23, 2021. On February 23, 2022, the reporting person reported the acquisition of the performance-based restricted stock unit award. One-third of the shares vested on February 23, 2022, one-third of the shares vested on February 23, 2023, and the remaining one-third vested on February 23, 2024, subject to adjustment based on the Company's relative total shareholder return ("TSR") over the measurement period starting on January 1, 2021, through to December 31, 2023. As a result of the Company's relative TSR, the third tranche was adjusted downward by 15%. As such, the reporting person received 245 less shares than the amount initially reported.

SEC source: 0001127602-24-006839 · form4.xml · nonDerivative · entry 1

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,485.383

F1 · balance_after: Reflects a downward adjustment of 805 shares of a performance-based restricted stock unit award granted on February 23, 2021. On February 23, 2022, the reporting person reported the acquisition of the performance-based restricted stock unit award. One-third of the shares vested on February 23, 2022, one-third of the shares vested on February 23, 2023, and the remaining one-third vested on February 23, 2024, subject to adjustment based on the Company's relative total shareholder return ("TSR") over the measurement period starting on January 1, 2021, through to December 31, 2023. As a result of the Company's relative TSR, the third tranche was adjusted downward by 15%. As such, the reporting person received 805 less shares than the amount initially reported.

SEC source: 0001127602-24-006575 · form4.xml · derivative · entry 3

Holmes Joseph R. · CIK 0001839832 · VP & Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 907

Underlying: Common Stock · 907 shares

Expires 2032-02-21

F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2025.

SEC source: 0001127602-24-006575 · form4.xml · nonDerivative · entry 2

Holmes Joseph R. · CIK 0001839832 · VP & Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,840.1457

F2 · shares: Shares represent a performance-based restricted stock unit award granted on February 22, 2023. The Company's Compensation Committee certified the achievement of this award on February 21, 2024. One-third of the shares vest on February 28, 2024 and 2025. The remaining one-third will vest on February 28, 2026, and is subject to adjustment (positive or negative) for long-term performance which is based on the comparison of the Company's total shareholder return compound annual growth rate ("CAGR") to the total shareholder return CAGR of each of the companies in the peer group, as specified within the award agreement, over the measurement period starting on January 1, 2023, through to December 31, 2025.

SEC source: 0001127602-24-006575 · form4.xml · nonDerivative · entry 1

Holmes Joseph R. · CIK 0001839832 · VP & Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,719.1457

F1 · balance_after: Includes 9.7447 shares acquired under the Issuer's employees' stock purchase plan on November 15, 2023.

SEC source: 0001127602-24-006583 · form4.xml · derivative · entry 4

Williamson Stephen · CIK 0001648929 · Sr. VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2027-09-09

F3 · shares: This performance-based stock option award was granted on September 9, 2020. The Company's Compensation Committee certified on February 21, 2024 that the performance criteria related to this award were satisfied.

SEC source: 0001127602-24-006583 · form4.xml · derivative · entry 3

Williamson Stephen · CIK 0001648929 · Sr. VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,250

Underlying: Common Stock · 12,250 shares

Expires 2032-02-21

F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2025.

SEC source: 0001127602-24-006583 · form4.xml · nonDerivative · entry 1

Williamson Stephen · CIK 0001648929 · Sr. VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,906.648

F1 · balance_after: On November 15, 2022, the reporting person contributed 18,700 shares of TMO common stock to a grantor retained annuity trust. On December 7, 2023, 9,856 shares were distributed by the trust to the reporting person and will continue to be reported in this Form 4 as directly owned.

SEC source: 0001127602-24-006591 · form4.xml · derivative · entry 3

Pettiti Gianluca · CIK 0001844600 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,300

Underlying: Common Stock · 14,300 shares

Expires 2027-09-09

F2 · shares: This performance-based stock option award was granted on September 9, 2020. The Company's Compensation Committee certified on February 21, 2024 that the performance criteria related to this award were satisfied.

SEC source: 0001127602-24-006591 · form4.xml · derivative · entry 2

Pettiti Gianluca · CIK 0001844600 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,047

Underlying: Common Stock · 13,047 shares

Expires 2032-02-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2025.

SEC source: 0001127602-24-006591 · form4.xml · nonDerivative · entry 1

Pettiti Gianluca · CIK 0001844600 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,648.67

SEC source: 0001127602-24-006601 · form4.xml · derivative · entry 3

Lagarde Michel · CIK 0001518973 · Executive Vice President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,870

Underlying: Common Stock · 22,870 shares

Expires 2027-09-09

F2 · shares: This performance-based stock option award was granted on September 9, 2020. The Company's Compensation Committee certified on February 21, 2024 that the performance criteria related to this award were satisfied.

SEC source: 0001127602-24-006601 · form4.xml · derivative · entry 2

Lagarde Michel · CIK 0001518973 · Executive Vice President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,179

Underlying: Common Stock · 14,179 shares

Expires 2032-02-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2025.

SEC source: 0001127602-24-006601 · form4.xml · nonDerivative · entry 1

Lagarde Michel · CIK 0001518973 · Executive Vice President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,962.565

SEC source: 0001127602-24-006622 · form4.xml · derivative · entry 3

Britt Lisa P. · CIK 0001676320 · Sr. VP and Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,440

Underlying: Common Stock · 11,440 shares

Expires 2027-09-09

F2 · shares: This performance-based stock option award was granted on September 9, 2020. The Company's Compensation Committee certified on February 21, 2024 that the performance criteria related to this award were satisfied.

SEC source: 0001127602-24-006622 · form4.xml · derivative · entry 2

Britt Lisa P. · CIK 0001676320 · Sr. VP and Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,990

Underlying: Common Stock · 4,990 shares

Expires 2032-02-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2025.

SEC source: 0001127602-24-006622 · form4.xml · nonDerivative · entry 1

Britt Lisa P. · CIK 0001676320 · Sr. VP and Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,765.069

SEC source: 0001127602-24-006633 · form4.xml · derivative · entry 3

Boxer Michael A · CIK 0001726596 · SVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,440

Underlying: Common Stock · 11,440 shares

Expires 2027-09-09

F2 · shares: This performance-based stock option award was granted on September 9, 2020. The Company's Compensation Committee certified on February 21, 2024 that the performance criteria related to this award were satisfied.

SEC source: 0001127602-24-006633 · form4.xml · derivative · entry 2

Boxer Michael A · CIK 0001726596 · SVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,990

Underlying: Common Stock · 4,990 shares

Expires 2032-02-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2025.

SEC source: 0001127602-24-006633 · form4.xml · nonDerivative · entry 1

Boxer Michael A · CIK 0001726596 · SVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,702.057

SEC source: 0001127602-24-006640 · form4.xml · derivative · entry 2

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,730

Underlying: Common Stock · 53,730 shares

Expires 2027-09-09

F2 · shares: This performance-based stock option award was granted on September 9, 2020. The Company's Compensation Committee certified on February 21, 2024 that the performance criteria related to this award were satisfied.

SEC source: 0001127602-24-006640 · form4.xml · derivative · entry 1

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,374

Underlying: Common Stock · 45,374 shares

Expires 2032-02-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2025.

SEC source: 0001127602-24-005780 · form4.xml · nonDerivative · entry 3

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Floral Park Associates, Inc.

Disclosed balance after: 43,608

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, entered into on March 3, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.15 to $552.72, inclusive.

SEC source: 0001127602-24-005780 · form4.xml · nonDerivative · entry 2

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Floral Park Associates, Inc.

Disclosed balance after: 43,908

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, entered into on March 3, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.14 to $552.04, inclusive.

SEC source: 0001127602-24-005780 · form4.xml · nonDerivative · entry 1

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Floral Park Associates, Inc.

Disclosed balance after: 44,708

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, entered into on March 3, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $550.00 to $550.96, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

SEC source: 0001127602-24-005038 · form4.xml · nonDerivative · entry 1

Spar Debora L · CIK 0001523191 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,207

SEC source: 0001127602-24-004031 · form4.xml · nonDerivative · entry 8

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Floral Park Associates, Inc.

Disclosed balance after: 49,155

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, entered into on March 3, 2023.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $561.92 to $562.64, inclusive.

SEC source: 0001127602-24-004031 · form4.xml · nonDerivative · entry 7

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Floral Park Associates, Inc.

Disclosed balance after: 49,537

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, entered into on March 3, 2023.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $560.83 to $561.63, inclusive.

SEC source: 0001127602-24-004031 · form4.xml · nonDerivative · entry 6

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Floral Park Associates, Inc.

Disclosed balance after: 49,937

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, entered into on March 3, 2023.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $557.58 to $557.90, inclusive.

SEC source: 0001127602-24-004031 · form4.xml · nonDerivative · entry 5

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Floral Park Associates, Inc.

Disclosed balance after: 50,137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, entered into on March 3, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $556.55 to $557.13, inclusive.

SEC source: 0001127602-24-004031 · form4.xml · nonDerivative · entry 4

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Floral Park Associates, Inc.

Disclosed balance after: 51,037

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, entered into on March 3, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.33 to $556.26, inclusive.

SEC source: 0001127602-24-004031 · form4.xml · nonDerivative · entry 3

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Floral Park Associates, Inc.

Disclosed balance after: 54,268

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, entered into on March 3, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.25 to $555.20, inclusive.

SEC source: 0001127602-24-004031 · form4.xml · nonDerivative · entry 2

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Floral Park Associates, Inc.

Disclosed balance after: 57,395

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, entered into on March 3, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.24 to $554.14, inclusive.

SEC source: 0001127602-24-004031 · form4.xml · nonDerivative · entry 1

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Floral Park Associates, Inc.

Disclosed balance after: 57,995

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, entered into on March 3, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.16 to $553.00, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8) and (9) to this Form 4.

SEC source: 0001127602-24-004033 · form4.xml · derivative · entry 3

Boxer Michael A · CIK 0001726596 · SVP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,566 shares

Expires 2025-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-24-004033 · form4.xml · nonDerivative · entry 2

Boxer Michael A · CIK 0001726596 · SVP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,901.057

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2023.